Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

John March


Board of Directors
Archrival
Liechtenstein

Biography

John has been involved in biotechnology commercialisation since 2007, when he set up BigDNA Ltd as an academic spin out. Since that time he has raised more than £4.3M of equity funding and was instrumental in licensing out BigDNA’s phage-based DNA vaccine technology to Eli Lilly animal health. 

Research Interest

 Research

Global Experts from Liechtenstein

Global Experts in Subject